23 May 2013
Keywords: uprima, filed, first, competition, oral, impotence, market
Article | 06 July 1999
TAP Holdings, the joint venture between Abbott Laboratories and TakedaChemical Industries, has filed for approval in the USA of Uprima ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.